These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11368422)

  • 1. The role of adjuvants in the efficacy of a peptide vaccine for myasthenia gravis.
    McAnally JL; Xu L; Villain M; Blalock JE
    Exp Biol Med (Maywood); 2001 Apr; 226(4):307-11. PubMed ID: 11368422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of complementary peptides and their antibodies in B-cell-mediated autoimmune disease: prevention of experimental autoimmune myasthenia gravis with a peptide vaccine.
    Araga S; Blalock JE
    Immunomethods; 1994 Oct; 5(2):130-5. PubMed ID: 7874437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor-specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Luo J; Lindstrom J
    Ann N Y Acad Sci; 2018 Feb; 1413(1):76-81. PubMed ID: 29377167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis.
    Allman W; Qi H; Saini SS; Li J; Tuzun E; Christadoss P
    J Neuroimmunol; 2012 Aug; 249(1-2):1-7. PubMed ID: 22626443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.
    Milani M; Ostlie N; Wu H; Wang W; Conti-Fine BM
    J Neuroimmunol; 2006 Oct; 179(1-2):152-62. PubMed ID: 16945426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.
    Maruta T; Oshima M; Mosier DR; Atassi MZ
    Autoimmunity; 2017 Aug; 50(5):293-305. PubMed ID: 28548588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
    Fuchs S; Aricha R; Reuveni D; Souroujon MC
    J Autoimmun; 2014 Nov; 54():51-9. PubMed ID: 24970384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help.
    Araga S; Xu L; Nakashima K; Villain M; Blalock JE
    FASEB J; 2000 Jan; 14(1):185-96. PubMed ID: 10627293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenic role of acetylcholine receptor alpha chain epitope within alpha 146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice.
    Shenoy M; Goluszko E; Christadoss P
    Clin Immunol Immunopathol; 1994 Dec; 73(3):338-43. PubMed ID: 7955562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats.
    Baggi F; Annoni A; Ubiali F; Milani M; Longhi R; Scaioli W; Cornelio F; Mantegazza R; Antozzi C
    J Immunol; 2004 Feb; 172(4):2697-703. PubMed ID: 14764745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
    Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis.
    Duan RS; Wang HB; Yang JS; Scallon B; Link H; Xiao BG
    J Autoimmun; 2002 Dec; 19(4):169-74. PubMed ID: 12473237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis.
    Poussin MA; Tüzün E; Goluszko E; Scott BG; Yang H; Franco JU; Christadoss P
    J Immunol; 2003 Apr; 170(8):4389-96. PubMed ID: 12682276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
    Oshima M; Iida-Klein A; Maruta T; Deitiker PR; Atassi MZ
    Autoimmunity; 2017 Sep; 50(6):346-353. PubMed ID: 28850269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.